SpaceX is performing a test flight of Starship SN15. The prototype will aim to be the first Starship vehicle to softly land during a high altitude flight test. Like the previous Starship prototypes, SN15 is expected to fly to approximately 10 kilometers.
SpaceX has once again scrubbed the latest major flight test of its Starship rocket. The next-generation spacecraft was set to launch from SpaceX’s Starbase facility in Boca Chica, Texas, on Tuesday, but cancelled it for reasons unknown.
Starship SN15’s high-altitude flight test follows four previous attempts that all ended in massive explosions. SpaceX boss Elon Musk said previous issues with the rocket’s Raptor engines have been fixed “six ways to Sunday”, though if it fails to land cleanly there are more Starship prototypes currently under development.
Airspace clearance had been approved by the Federal Aviation Administration (FAA), road closures were in place with Cameron County, and marine hazard notices had been issued. The test was expected to take place between 12pm and 8pm local time (6pm — 2am BST) on Tuesday, however a backup launch window is also in place for Wednesday.
Genetic treatments are difficult to produce without facilities.
After Kelli Luginbuhl finished her PhD, her advisor, Duke bioengineer and PhaseBio co-founder Ashutosh Chilkoti, sat her down and asked if she wanted to launch and then run a company. Chilkoti had a once-obscure technology he and the venture capitalist Joe McMahon thought could form the basis of his second company and finally pay huge dividends. Luginbuhl knew the tech from years in his lab and was already looking for biotech jobs. It all added up.
Three years, some strategizing, and 10 or so pitch meetings later, the trio is launching Isolere Bio, with $7 million in seed funding led by Northpond Ventures and technology they believe can allow gene therapy companies to vastly increase the number of doses they can produce. It’s one potential solution to a slow-boiling crisis that has become increasingly acute, as new companies struggle to get the materials they need for trials and some common diseases remain theoretically unfixable by gene therapy, because companies would never be able to make enough doses for that many patients.
The problem is partially that the facilities don’t yet exist to produce this much of gene therapy. Experts, however, also point to antiquated manufacturing processes.
In diabetic nephropathy—a common cause of kidney disease—levels of NEDD4-2 are severely reduced. This is the case even when salt is not a factor.
University of South Australia researchers have identified an enzyme that may help to curb chronic kidney disease, which affects approximately 700 million people worldwide.
This enzyme, NEDD4-2, is critical for kidney health, says UniSA Centre for Cancer Biology scientist Dr. Jantina Manning in a new paper published this month in Cell Death & Disease.
The early career researcher and her colleagues, including 2020 SA Scientist of the Year Professor Sharad Kumar, have shown in an animal study the correlation between a high salt diet, low levels of NEDD4-2 and advanced kidney disease.
Access to clean water may be a right, but it’s often hard to come by. Contaminated water kills. Henry Othieno and Saudah Birungi have developed eco-friendly filters for use in schools and homes. They turn dirty lake water into drinking water.
“Programmable matter” technique could enable product designers to churn out prototypes with ease.
When was the last time you repainted your car? Redesigned your coffee mug collection? Gave your shoes a colorful facelift?
You likely answered: never, never, and never. You might consider these arduous tasks not worth the effort. But a new color-shifting “programmable matter” system could change that with a zap of light.
LumiLor is an electroluminescent coating system which allows anything coated with it to function as a light. Electroluminescence simply means that an object is capable of emitting light when an electrical current passes through it.
The lifespan of LumiLor is dependent on how much power is applied and the native LumiLor color used. More power equals brighter light but a shorter half life.
The life of the product has been measured over 10000 hours, and in some up to 50000 hours.
Charging and discharging LumiLor does not affect the half-life. LumiLor only degrades towards its half life when it is charged.
The Lumicolor layer is currently available in white, blue, aqua, green, orange, Yellow, Violet and Pink colors.
Lumilor is available in 8 colours — white, blue, aqua, green, orange, Yellow, Violet and Pink and the lighting sequence can be controlled in various ways, such as – simple on or off, strobe effect, sequencing, and motion & sound activation.
Computing experts thought they had developed adequate security patches after the major worldwide Spectre flaw of 2018, but UVA’s discovery shows processors are open to hackers again.
In 2018, industry and academic researchers revealed a potentially devastating hardware flaw that made computers and other devices worldwide vulnerable to attack.
Researchers named the vulnerability Spectre because the flaw was built into modern computer processors that get their speed from a technique called “speculative execution,” in which the processor predicts instructions it might end up executing and preps by following the predicted path to pull the instructions from memory. A Spectre attack tricks the processor into executing instructions along the wrong path. Even though the processor recovers and correctly completes its task, hackers can access confidential data while the processor is heading the wrong way.